ici d2138 has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charlier, C; Durant, F; Goossens, JF; Goossens, L; Hénichart, JP; Houssin, R; Pommery, J; Pommery, N; Taverne, T; Telliez, A | 1 |
| Bridoux, A; Henichart, JP; Millet, R; Pommery, J; Pommery, N | 1 |
2 other study(ies) available for ici d2138 and Cancer of Prostate
| Article | Year |
|---|---|
New COX-2/5-LOX inhibitors: apoptosis-inducing agents potentially useful in prostate cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Cell Proliferation; CHO Cells; Cricetinae; Cyclooxygenase 2; Drug Screening Assays, Antitumor; Humans; Isoenzymes; Lipoxygenase Inhibitors; Male; Membrane Proteins; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Pyrazoles; Structure-Activity Relationship | 2004 |
Synthesis and biological activity of N-aroyl-tetrahydro-gamma-carbolines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbolines; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase Inhibitors; Humans; Indomethacin; Lipoxygenase Inhibitors; Male; Prostatic Neoplasms; Structure-Activity Relationship | 2010 |